Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Encompass Health CorpEHC · Entity 3460 | Director · President & CEO | August 10, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Encompass Health Corp
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 267,814 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-10 · Sale · Disposed 171,569 · Balance 269,393 F1: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.92, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Row 2 · 2026-08-10 · Sale · Disposed 1,579 · Balance 267,814 F2: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.93 to $126.22, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
Filing footnotes · ownership attribution and instrument terms
F1: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.92, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.93 to $126.22, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2022 Filed Aug 19, 2022 13:04 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 20,449 | $53.25 | $1,088,909.25 |
DisclosureSEC source: 0001127602-22-021346 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,895 F2 · price: This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.24 to $53.25, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 13:04 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 20,449 | $20.07 | $410,411.43 |
DisclosureSEC source: 0001127602-22-021346 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total share holdings reported in this column include the adjustment of outstanding restricted stock awards, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:56 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 61,039 | $0.00 Strike: $66.39 | $0.00 |
DisclosureSEC source: 0001127602-22-007738 · form4.xml · derivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,039 Underlying: Encompass Health Common Stock · 61,039 shares Expires 2032-03-01 F1 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 1, 2023. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 18:49 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 31,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006970 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,557 F3 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 18:49 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 16,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006970 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,827 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 18:49 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 1,873 | $65.52 | $122,718.96 |
DisclosureSEC source: 0001127602-22-006970 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,569 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:51 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 3,782 | $65.91 | $249,271.62 |
DisclosureSEC source: 0001127602-22-006355 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,442 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:19 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 11,327 | $65.26 | $739,200.02 |
DisclosureSEC source: 0001127602-22-000857 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,224 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 19:14 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 53,410 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-21-009368 · form4.xml · derivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,410 Underlying: Encompass Health Common Stock · 53,410 shares Expires 2031-03-02 F1 · shares: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:27 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 12,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007895 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,551 F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:27 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 30,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007895 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,882 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:27 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 1,975 | $80.23 | $158,454.25 |
DisclosureSEC source: 0001127602-21-007895 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,414 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 22:18 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,039 | $80.51 | $164,159.89 |
DisclosureSEC source: 0001127602-21-007370 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,389 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 22:18 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 1,743 | $80.51 | $140,328.93 |
DisclosureSEC source: 0001127602-21-007370 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,428 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 14:53 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 22,894 | $82.69 | $1,893,104.86 |
DisclosureSEC source: 0001127602-21-000879 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,171 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| May 14, 2020 Filed May 14, 2020 20:28 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 26,132 | $0.00 Strike: $21.02 | $0.00 |
DisclosureSEC source: 0001127602-20-016572 · form4.xml · derivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 26,132 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 14, 2020 20:28 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 26,132 | $61.92 | $1,618,093.44 |
DisclosureSEC source: 0001127602-20-016572 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,065 F1 · price: This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.31 to $62.30, inclusive. Read SEC document |
| May 14, 2020 Filed May 14, 2020 20:28 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 26,132 | $21.02 | $549,294.64 |
DisclosureSEC source: 0001127602-20-016572 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:41 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 55,360 | $0.00 Strike: $76.54 | $0.00 |
DisclosureSEC source: 0001127602-20-009353 · form4.xml · derivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,360 Underlying: Encompass Health Common Stock · 55,360 shares Expires 2030-03-02 F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2021. Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 17:03 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 1,975 | $81.64 | $161,239.00 |
DisclosureSEC source: 0001127602-20-007501 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,065 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:03 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,040 | $81.64 | $166,545.60 |
DisclosureSEC source: 0001127602-20-007501 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,040 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2020 Filed Feb 20, 2020 21:30 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 11,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006676 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,080 F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 20, 2020 Filed Feb 20, 2020 21:30 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 55,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006676 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,291 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 23, 2018. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:30 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,005 | $82.61 | $165,633.05 |
DisclosureSEC source: 0001127602-20-006676 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,776 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 19:21 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 20,596 | $69.27 | $1,426,684.92 |
DisclosureSEC source: 0001127602-20-000483 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,781 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 23,501 | $0.00 Strike: $24.21 | $0.00 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · derivative · entry 8 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 23,501 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal installments on the anniversaries of the grant date beginning on the date set forth. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 33,331 | $0.00 Strike: $17.30 | $0.00 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · derivative · entry 7 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 33,331 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal installments on the anniversaries of the grant date beginning on the date set forth. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 10,550 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · derivative · entry 6 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 10,550 shares Expires 2019-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal installments on the anniversaries of the grant date beginning on the date set forth. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 23,943 | $63.23 | $1,513,915.89 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 5 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,377 F2 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.07 to $63.31, exclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 43,439 | $63.74 | $2,768,801.86 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 4 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,320 F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.31 to $64.30, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 23,501 | $24.21 | $568,959.21 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 33,331 | $17.30 | $576,626.30 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 10,550 | $14.95 | $157,722.50 |
DisclosureSEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:44 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 57,572 | $0.00 Strike: $63.77 | $0.00 |
DisclosureSEC source: 0001127602-19-009466 · form4.xml · derivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,572 Underlying: Encompass Health Common Stock · 57,572 shares Expires 2029-03-01 F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2020. Read SEC document |
| February 25, 2019 Filed Feb 26, 2019 22:20 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 1,975 | $65.87 | $130,093.25 |
DisclosureSEC source: 0001127602-19-008426 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,377 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 21, 2019 Filed Feb 21, 2019 19:58 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 51,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-007466 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,352 F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017. Read SEC document |
| February 21, 2019 Filed Feb 21, 2019 19:58 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 13,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-007466 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,256 F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 20:03 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 3,089 | $67.19 | $207,549.91 |
DisclosureSEC source: 0001127602-19-007102 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,464 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 23:25 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 9,410 | $61.70 | $580,597.00 |
DisclosureSEC source: 0001127602-19-000940 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,553 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| May 01, 2018 Filed May 2, 2018 19:21 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 33,100 | $0.00 Strike: $7.85 | $0.00 |
DisclosureSEC source: 0001127602-18-015935 · form4.xml · derivative · entry 4 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 33,100 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2018 Filed May 2, 2018 19:21 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 16,575 | $61.32 | $1,016,379.00 |
DisclosureSEC source: 0001127602-18-015935 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,963 F2 · price: This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.575, inclusive. Read SEC document |
| May 01, 2018 Filed May 2, 2018 19:21 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 16,525 | $60.60 | $1,001,415.00 |
DisclosureSEC source: 0001127602-18-015935 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,538 F1 · price: This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (2) below. Read SEC document |
| May 01, 2018 Filed May 2, 2018 19:21 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 33,100 | $7.85 | $259,835.00 |
DisclosureSEC source: 0001127602-18-015935 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:49 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 51,547 | $0.00 Strike: $53.79 | $0.00 |
DisclosureSEC source: 0001127602-18-010002 · form4.xml · derivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,547 Underlying: Healthsouth Common Stock · 51,547 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2019. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 22:38 UTC | Encompass Health Corp EHC · Entity 3460 | GrantHealthsouth Common Stock | 13,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-008482 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,963 F2 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 22:38 UTC | Encompass Health Corp EHC · Entity 3460 | GrantHealthsouth Common Stock | 26,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-008482 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,604 F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 18, 2016. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:16 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingHealthsouth Common Stock | 3,320 | $52.10 | $172,972.00 |
DisclosureSEC source: 0001127602-18-007543 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,145 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 20:32 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingHealthsouth Common Stock | 5,044 | $49.41 | $249,224.04 |
DisclosureSEC source: 0001127602-18-000518 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,465 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:25 UTC | Encompass Health Corp HLS · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 22,625 | $0.00 Strike: $16.27 | $0.00 |
DisclosureSEC source: 0001127602-17-025233 · form4.xml · derivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Healthsouth Common Stock · 22,625 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:25 UTC | Encompass Health Corp HLS · Entity 3460 | SaleHealthsouth Common Stock | 22,625 | $43.00 | $972,875.00 |
DisclosureSEC source: 0001127602-17-025233 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,509 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.